Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0950
-0.0550 (-2.56%)
NASDAQ · Last Trade: Sep 24th, 11:46 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors